SMTL ID : 5wdy.2 (1 other biounit)

Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.46 Å

Oligo State

monomer

Ligands

1 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 3 residues within 4Å: Chain A: N.150, D.164 Ligands: ANP.2 No protein-ligand interaction detected (PLIP)

1 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.2: 13 residues within 4Å: Chain A: R.25, G.26, S.27, K.29, V.31, A.44, T.97, E.98, L.99, M.100, F.152, D.164 Ligands: MN.1 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:R.25, A:S.27, A:T.97, A:E.98, A:M.100, A:D.164 Salt bridges: A:K.29

1 x A6S: 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine(Non-covalent)

A6S.3: 16 residues within 4Å: Chain A: K.29, F.61, E.64, A.65, L.68, L.71, V.77, F.79, S.82, L.95, T.97, D.164, L.165, G.166, A.168, L.170 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.68, A:L.68, A:V.77, A:F.79, A:F.79, A:L.95, A:T.97, A:L.165, A:L.170, A:L.170 Hydrogen bonds: A:E.64, A:L.165 pi-Stacking: A:F.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yamada, K. et al., Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models. J. Med. Chem. (2017)

Release Date

2017-08-16

Peptides

Serine/threonine-protein kinase WNK1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase WNK1

Related Entries With Identical Sequence